Sign in

CIK 0000318306

  • Non-accelerated filer
  • Smaller reporting company

ABEONA THERAPEUTICS INC.

Sign in to watch
Ticker
ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
830221517
Phone
+1 646-813-4701
Business address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
Former names
PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
Open-market buys, last 90 days
$34,349
in 1 filing
Open-market sales, last 90 days
$296,397
in 5 filings

Net −$262,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-12-14 Jeffrey B Davis COO Grant or award · Stock option (right to buy) +20,000 20,000
2017-12-14 Jeffrey B Davis COO Grant or award · Stock option (right to buy) +60,000 60,000
2016-12-13 Jeffrey B Davis Chief Operating Officer Grant or award · Stock option (right to buy) +37,500 37,500
2016-12-13 Jeffrey B Davis Chief Operating Officer Grant or award · Stock option (right to buy) +112,500 150,000
2016-02-11 Jeffrey B Davis Chief Operating Officer Grant or award · Stock option (right to buy) +37,500 37,500
2016-02-11 Jeffrey B Davis Chief Operating Officer Grant or award · Stock option (right to buy) +112,500 150,000
2015-05-11 Jeffrey B Davis Cheif Operating Officer Grant or award +300,000 300,000
2015-05-11 Jeffrey B Davis Cheif Operating Officer Grant or award · Stock option (right to buy) +100,000 100,000
2015-05-11 Jeffrey B Davis Chief Operating Officer Grant or award +300,000 $7.34 $2.2M 300,000
2015-05-11 Jeffrey B Davis Chief Operating Officer Grant or award · Stock option (right to buy) +100,000 $7.34 $734K 140,500
2014-12-24 Jeffrey B Davis Director Purchase +62,500 $4.00 $250K 67,858
2014-12-24 Jeffrey B Davis Director Other acquisition +594,801 $4.00 $2.4M 662,659
2014-12-24 Jeffrey B Davis Director Other acquisition +300,852 $4.00 $1.2M 963,511
2014-12-24 Jeffrey B Davis Director Purchase · Common Stock Purchase Warrants +62,500 $0.01 $625 62,500
2014-12-24 Jeffrey B Davis Director Conversion · Series A Cumulative Convertible Preferred Stock −237.92 $4.00 $952 0
2014-03-07 Jeffrey B Davis CEO Grant or award · Stock option (right to buy) +500,000 $0.37 $185K 525,000
2014-03-07 Jeffrey B Davis CEO Grant or award · Stock option (right to buy) +1,500,000 $0.37 $555K 2,025,000
2009-02-04 Jeffrey B Davis Chief Executive Officer Other acquisition +5,950 $3.00 $18K 173,250
2009-02-04 Jeffrey B Davis Chief Executive Officer Other acquisition +24,897 $2.75 $68K 173,250
2009-02-04 Jeffrey B Davis Chief Executive Officer Other acquisition +74,709 $0.96 $72K 173,250

Page 1 of 2 · 37 trades